Cocrystal Pharma, Inc. Quarterly Debt-to-equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cocrystal Pharma, Inc. quarterly Debt-to-equity history and growth rate from Q3 2014 to Q3 2024.
  • Cocrystal Pharma, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 20.9 %, a 267% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 20.9 +15.2 +267% Sep 30, 2024
Q2 2024 15.4 +10.5 +214% Jun 30, 2024
Q1 2024 10.8 +5.52 +104% Mar 31, 2024
Q4 2023 9.15 +5.48 +149% Dec 31, 2023
Q3 2023 5.71 +2.37 +71% Sep 30, 2023
Q2 2023 4.9 +1.98 +67.9% Jun 30, 2023
Q1 2023 5.29 +2.8 +112% Mar 31, 2023
Q4 2022 3.67 +1 +37.4% Dec 31, 2022
Q3 2022 3.34 +0.46 +16% Sep 30, 2022
Q2 2022 2.92 -0.94 -24.4% Jun 30, 2022
Q1 2022 2.49 -2.72 -52.2% Mar 31, 2022
Q4 2021 2.67 -3.22 -54.7% Dec 31, 2021
Q3 2021 2.88 -4.75 -62.3% Sep 30, 2021
Q2 2021 3.86 -2.67 -40.9% Jun 30, 2021
Q1 2021 5.21 +0.23 +4.62% Mar 31, 2021
Q4 2020 5.89 +1.57 +36.4% Dec 31, 2020
Q3 2020 7.63 +4.34 +132% Sep 30, 2020
Q2 2020 6.52 +0.38 +6.19% Jun 30, 2020
Q1 2020 4.98 -3.56 -41.7% Mar 31, 2020
Q4 2019 4.32 -7.14 -62.3% Dec 31, 2019
Q3 2019 3.29 -10.5 -76.1% Sep 30, 2019
Q2 2019 6.14 -10.1 -62.1% Jun 30, 2019
Q1 2019 8.54 -10.2 -54.5% Mar 31, 2019
Q4 2018 11.5 -8.94 -43.8% Dec 31, 2018
Q3 2018 13.8 -8.42 -38% Sep 30, 2018
Q2 2018 16.2 -9.28 -36.4% Jun 30, 2018
Q1 2018 18.8 -9.46 -33.5% Mar 31, 2018
Q4 2017 20.4 -10.1 -33% Dec 31, 2017
Q3 2017 22.2 -10.4 -31.9% Sep 30, 2017
Q2 2017 25.5 -8.06 -24% Jun 30, 2017
Q1 2017 28.2 -6.64 -19.1% Mar 31, 2017
Q4 2016 30.5 -6.69 -18% Dec 31, 2016
Q3 2016 32.6 -17.8 -35.3% Sep 30, 2016
Q2 2016 33.6 -25.7 -43.4% Jun 30, 2016
Q1 2016 34.9 -47.4 -57.6% Mar 31, 2016
Q4 2015 37.2 -658 -94.7% Dec 31, 2015
Q3 2015 50.3 +3.2K Sep 30, 2015
Q2 2015 59.3 Jun 30, 2015
Q1 2015 82.2 Mar 31, 2015
Q4 2014 695 Dec 31, 2014
Q3 2014 -3.15K Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.